The stock market rose again today, with more than 4,100 stocks rising, and the trading volume of the two markets increased to more than 1.3 trillion yuan. So far, the Shanghai Composite Index has risen for five consecutive days.
Peptide drugs and AI medicine are today's strong concepts.
Tomorrow is Tuesday, June 10. I think the stock market will continue to rise tomorrow, but there is a high possibility of a surge and a fall.
1. Today's market review
The three major stock indexes rose across the board today. As of the close, the Shanghai Composite Index rose 0.43%, the Shenzhen Component Index rose 0.65%, and the ChiNext Index rose 1.07%. The total trading volume increased compared with yesterday, with a total transaction volume of 131.28 billion yuan. The main funds had a small net inflow.
4171 stocks rose, 1112 stocks fell, 87 stocks hit the daily limit, and 4 stocks hit the daily limit.
The sectors with the highest growth rate are: sports, innovative drugs, aviation equipment, breeding industry, medical services, and rare earth permanent magnets.
The sectors with the largest declines are: liquor, gold concepts, and main consumption.
2. Market analysis
On the weekend, the media reported that many securities companies, futures companies and public funds of Central Huijin Holdings became the actual controllers. This information has become a boost to the stock market's rise today. The entire securities sector has risen, and it has not plunged at any time like before. It has performed relatively steadily today.
Today, the Shanghai Composite Index closed a small positive line with 3 points of the upper shadow line, 5 points of the lower shadow line, and 11 points of the entity. Judging from the daily K-line chart of the Shanghai Composite Index, the stock index is on an upward trend in the short term, but the closing point of the stock index is 3399 points, which is already facing a pressure zone above 3400 points, so I think the possibility of the stock index rising and falling tomorrow is relatively high.
The above is my personal opinion, for reference only and does not constitute investment advice.
